4,250,000 Shares1 ATRICURE, INC. Common Stock PURCHASE AGREEMENTPurchase Agreement • February 13th, 2014 • AtriCure, Inc. • Surgical & medical instruments & apparatus • New York
AtriCure, Inc., a Delaware corporation (the “Company”), and the stockholders of the Company listed in Schedule I hereto (the “Selling Stockholders”) severally propose to sell to the several underwriters named in Schedule II hereto (the “Underwriters”) an aggregate of 4,250,000 shares (the “Firm Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company. The Firm Shares consist of 3,023,025 authorized but unissued shares of Common Stock to be issued and sold by the Company and 1,226,975 outstanding shares of Common Stock to be sold by the Selling Stockholders. The Company has also granted to the several Underwriters an option to purchase up to 637,500 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
